Alcoholic hepatitis: How far are we and where are we going?
Document title: Alcoholic hepatitis: How far are we and where are we going?
Journal: Annals of hepatology
Database: PERIÓDICA
System number: 000407467
ISSN: 1665-2681
Authors: 1
1
2
3
2
Institutions: 1Hospital Clinic de Barcelona, Unidad de Cuidados Intensivos, Barcelona. España
2Universidad Autónoma de Barcelona, Hospital Vall d'Hebron, Barcelona. España
3University of North Carolina, Division of Gastroenterology and Hepatology, Chapel Hill, Carolina del Norte. Estados Unidos de América
Year:
Season: Jul-Ago
Volumen: 15
Number: 4
Pages: 463-473
Country: México
Language: Inglés
Document type: Artículo
Approach: Analítico, descriptivo
English abstract The burden of alcoholic liver disease continues to be a major public health problem worldwide. The spectrum of disease ranges from fatty liver to cirrhosis and hepatocellular carcinoma. Alcoholic hepatitis (AH) is a type of acute-on-chronic liver failure and the most severe form of alcoholic liver disease. Severe AH carries a poor short-term prognosis and its management is still challenging, with scarce advances in the last decades. Corticosteroids are still the first line of therapy in severe cases. Unfortunately, many patients do not respond and novel targeted therapies are urgently needed. Liver transplantation has shown extraordinary results in non-responders to corticosteroids however; its applicability is very low. This review summarizes the epidemiology, natural history, risk factors and pathogenesis of alcoholic liver disease with special focus on the latest advances in prognostic stratification and therapy of patients with alcoholic hepatitis
Disciplines: Medicina
Keyword: Gastroenterología,
Toxicología,
Hepatitis alcohólica,
Esteatohepatitis,
Patogénesis,
Factores de riesgo,
Corticosteroides
Keyword: Medicine,
Gastroenterology,
Toxicology,
Alcoholic hepatitis,
Steatohepatitis,
Pathogenesis,
Risk factors,
Corticosteroids
Full text: Texto completo (Ver PDF)